RhumbLine Advisers’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17
| Closed | -$36K | – | 3104 |
|
|
2022
Q1 | $36K | Buy |
17
+1
| +6% | +$2.12K | ﹤0.01% | 2990 |
|
|
2021
Q4 | $80K | Hold |
16
| – | – | ﹤0.01% | 2960 |
|
|
2021
Q3 | $103K | Hold |
16
| – | – | ﹤0.01% | 2992 |
|
|
2021
Q2 | $151K | Buy |
16
+7
| +78% | +$66.1K | ﹤0.01% | 2944 |
|
|
2021
Q1 | $77K | Hold |
9
| – | – | ﹤0.01% | 2957 |
|
|
2020
Q4 | $66K | Buy |
9
+2
| +29% | +$14.7K | ﹤0.01% | 3005 |
|
|
2020
Q3 | $49K | Sell |
7
-1
| -13% | -$7K | ﹤0.01% | 2950 |
|
|
2020
Q2 | $60K | Buy |
8
+2
| +33% | +$15K | ﹤0.01% | 3020 |
|
|
2020
Q1 | $43K | Hold |
6
| – | – | ﹤0.01% | 2872 |
|
|
2019
Q4 | $94K | Hold |
6
| – | – | ﹤0.01% | 2877 |
|
|
2019
Q3 | $57K | Hold |
6
| – | – | ﹤0.01% | 2919 |
|
|
2019
Q2 | $94K | Buy |
+6
| New | +$94K | ﹤0.01% | 2934 |
|